Nicolas Hubacz: Mesenchymal Stem Cells Are Some of the Most Fascinating Cells in Regenerative Medicine
Nicolas Hubacz, Research and Clinical Products Business Development Manager at Magstim, shared a post on LinkedIn:
“The Body’s Cellular Repair Crew, Mesenchymal stem cells (MSCs) are some of the most fascinating cells in regenerative medicine.
Found in bone marrow, fat tissue, umbilical cord tissue, and other organs, these cells can both transform into specialized cell types and influence healing through powerful signaling mechanisms.
What makes MSCs especially interesting is that their therapeutic potential may come less from ‘becoming new tissue’ and more from how they communicate with the immune system and damaged cells around them.
What MSCs can do:
- Modulate inflammation and immune responses
- Support tissue repair and wound healing
- Differentiate into bone, cartilage, muscle, and fat cells
- Release growth factors and extracellular vesicles that influence surrounding cells
- Serve as a major focus of regenerative medicine and bioengineering research
Researchers are actively studying MSCs in areas ranging from neurodegenerative disease and stroke recovery to orthopedic injury, autoimmune disorders, and cardiovascular disease.
The video of MSCs in motion is a reminder that biology is incredibly dynamic at the microscopic scale. These aren’t static structures — they constantly migrate, interact, signal, and adapt to their environment.
One of the most exciting shifts in recent years has been the growing understanding that stem cell therapies may work through entire cellular ecosystems, not just through cell replacement alone.
Credit to Nanolive SA for the great video!”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments